Penn Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,036,995
Closed -$7.23M 168
2025
Q3
$7.23M Buy
1,036,995
+291,118
+39% +$2.05M 0.56% 78
2025
Q2
$4.42M Buy
745,877
+103,783
+16% +$597K 0.38% 73
2025
Q1
$4.11M Buy
+642,094
New +$6.19M 0.4% 75
2024
Q2
Sell
-537,369
Closed -$9.47M 149
2024
Q1
$9.47M Sell
537,369
-182,312
-25% -$2.69M 0.84% 63
2023
Q4
$11.4M Sell
719,681
-70,255
-9% -$725K 1.04% 46
2023
Q3
$6.8M Buy
789,936
+24,915
+3% +$177K 0.7% 66
2023
Q2
$6.04M Sell
765,021
-128,546
-14% -$895K 0.59% 69
2023
Q1
$6.69M Buy
893,567
+203,086
+29% +$2.02M 0.67% 66
2022
Q4
$8.15M Buy
+690,481
New +$7.89M 0.83% 61

Other funds holding ASPN

Penn Capital Management's ASPN Position: Q4 2025 in Review

Penn Capital Management sold out of Aspen Aerogels (ASPN) in Q4 2025, closing a stake of 1,036,995 shares — an estimated $7.23M sold.

Penn Capital Management first reported a position in ASPN in Q4 2022 and held it in 9 quarters. The position peaked at $11.4M in Q4 2023. 183 funds tracked by Wall St. Rank hold ASPN as of Q4 2025.

  • Penn Capital Management reported no remaining Aspen Aerogels position as of Q4 2025 after selling out during the quarter.
  • Penn Capital Management sold 1,036,995 Aspen Aerogels shares in Q4 2025, an estimated $7.23M.
  • Penn Capital Management first reported a position in Aspen Aerogels in Q4 2022 and held it in 9 quarters.
  • Penn Capital Management's Aspen Aerogels position peaked at $11.4M in Q4 2023.
  • 183 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2025.

Based on Penn Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.